Beta Bionics (BBNX) EBT Margin (2024 - 2026)
Beta Bionics recorded quarterly EBT Margin of 79.26% in Q1 2026, down 89.05% quarter-over-quarter from 41.92% in Q4 2025, and up 1262.0% year-over-year from 5.82% in Q1 2025.
Beta Bionics' EBT Margin history runs 3 years deep, the most recent figure standing at 79.26% for Q1 2026.
- In Q1 2026, EBT Margin rose 1262.0% year-over-year to 79.26%; the TTM figure through Mar 2026 stood at 60.27% (up 1024.0% YoY), while the FY2025 annual figure was 60.6%, up 289.0% from the prior year.
- EBT Margin came in at 79.26% for Q1 2026 at Beta Bionics, down from 41.92% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 41.92% in Q4 2025 to a low of 91.88% in Q1 2025.
- A 3-year average of 65.96% and a median of 64.29% in 2024 frame the typical range for EBT Margin.
- On a YoY basis, EBT Margin climbed as much as 1721 bps in 2025 and fell as far as 2759 bps in 2025.
- Beta Bionics' EBT Margin stood at 59.13% in 2024, then gained by 29 bps to 41.92% in 2025, then tumbled by 89 bps to 79.26% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 79.26%, 41.92%, and 52.14% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Beta Bionics | 572.34 Mn | 542.03 Mn | 16.44 Mn | -79.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.26% |
| Dec 31, 2025 | -41.92% |
| Sep 30, 2025 | -52.14% |
| Jun 30, 2025 | -72.58% |
| Mar 31, 2025 | -91.88% |
| Dec 31, 2024 | -59.13% |
| Sep 30, 2024 | -60.77% |
| Jun 30, 2024 | -71.72% |
| Mar 31, 2024 | -64.29% |